Skip to main content
. Author manuscript; available in PMC: 2009 Nov 18.
Published in final edited form as: Arch Ophthalmol. 2008 Oct;126(10):1336–1349. doi: 10.1001/archopht.126.10.1336

Figure 3. Cumulative distribution of CI Symptom Survey data collected during the eligibility examination and at the week 12 masked examination, by treatment group.

Figure 3

3A. Baseline examination

3B. Outcome Examination